BlackRock Amends EXACT SCIENCES CORP Stake as of Dec 31, 2023

TL;DR

**BlackRock updated its passive stake in Exact Sciences; watch for market reaction.**

AI Summary

BlackRock Inc. filed an amended SC 13G/A on January 29, 2024, indicating a change in their ownership of EXACT SCIENCES CORP's common stock as of December 31, 2023. This amendment, number 2, updates their previous disclosures regarding their passive investment in the medical laboratories company. This matters to investors because BlackRock is a major institutional investor, and changes in their holdings can signal their confidence (or lack thereof) in the company's future prospects, potentially influencing other investors.

Why It Matters

This filing shows BlackRock's updated position in Exact Sciences, which can influence market perception and potentially the stock price due to their significant institutional presence.

Risk Assessment

Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate or significant risk to the company.

Analyst Insight

Investors should note BlackRock's continued, albeit updated, passive interest in Exact Sciences, but this filing alone doesn't provide enough detail to warrant immediate action. Further analysis of the specific share count changes (which are not provided in this excerpt) would be necessary to gauge the significance of this amendment.

Key Players & Entities

• BlackRock Inc. (company) — the reporting person filing the SC 13G/A
• EXACT SCIENCES CORP (company) — the subject company whose securities are being reported
• December 31, 2023 (date) — the date of the event requiring the filing
• January 29, 2024 (date) — the filing date of the SC 13G/A

FAQ

From the Filing

0001086364-24-005590.txt : 20240129 0001086364-24-005590.hdr.sgml : 20240129 20240129172551 ACCESSION NUMBER: 0001086364-24-005590 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240129 DATE AS OF CHANGE: 20240129 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-62447 FILM NUMBER: 24574913 BUSINESS ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us30063p1057_012924.txt us30063p1057_012924.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) EXACT SCIENCES CORP -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 30063P105 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 30063P105 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 9881073 (6) Shared voting power 0 (7) Sole dispositive power 11103191 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 11103191 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 6.1% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- EXACT SCIENCES CORP Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 5505 ENDEAVOR LANE MADISON WI 53719 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Addre